Sorrento Therapeutics, Inc.

Insider Reports History

Location
San Diego, CA
Signature
By: /s/ Mohsin Y. Meghji Chief Restructuring Officer of Sorrento Therapeutics, Inc.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sorrento Therapeutics, Inc.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Scilex Holding Co 10%+ Owner Common Stock 1,917,210 $1,687,145 $0.8800 21 Sep 2023 Direct
Celularity Inc 10%+ Owner Class A Common Stock 5,050,427 $1,257,556 $0.2490 05 Oct 2023 Direct
Scilex Holding Co 10%+ Owner Warrants to Purchase Common Stock 0 $0.3507 21 Sep 2023 Direct

Insider Reports Filed by Sorrento Therapeutics, Inc.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CELU Celularity Inc 29 Sep 2023 2 $0 4 10%+ Owner 05 Oct 2023, 17:16
SCLX Scilex Holding Co 21 Sep 2023 2 $0 4 10%+ Owner 25 Sep 2023, 16:27
SCLX Scilex Holding Co 19 Jan 2023 1 $0 4 10%+ Owner 23 Jan 2023, 15:11
SCLX Scilex Holding Co 02 Dec 2022 1 +$78,852 4 10%+ Owner 02 Dec 2022, 18:21
SCLX Scilex Holding Company/DE 25 Nov 2022 1 +$20,196 4 10%+ Owner 25 Nov 2022, 14:21
SCLX Scilex Holding Company/DE 23 Nov 2022 1 +$175,670 4 10%+ Owner 23 Nov 2022, 16:59
SCLX Scilex Holding Company/DE 22 Nov 2022 1 +$152,047 4 10%+ Owner 22 Nov 2022, 18:24
SCLX Vickers Vantage Corp. I 10 Nov 2022 2 $0 4 10%+ Owner 15 Nov 2022, 17:38
SCLX Vickers Vantage Corp. I 10 Nov 2022 0 $0 3 10%+ Owner 15 Nov 2022, 17:27
CELU Celularity Inc 16 Jul 2021 0 $0 3 10%+ Owner 23 Jul 2021, 06:04